TapImmune Inc (OTC:TPIV) announced Monday 04/16/12 that  they have signed an Exclusive Agreement with the Mayo Foundation for Education & Research, Rochester, MN, to License a proprietary MHC Class I HER2/neu antigen technology. TPIV volume has been increasing over the past week. TPIV operates within the multi-billion dollar biotechnology industry, specializing in the development of innovative therapeutics and vaccines in the areas of oncology and infectious disease. The company’s lead product, the TAP vaccine, performs a key step in moving characteristic markers called antigens to the surfaces of cells. The company is also developing TAP-based prophylactic vaccines commercially which are suitable for the prevention of infectious diseases and as Biodefense agents. TPIV has issued several key announcements recently which are sure to capture the market’s attention. This morning TPIV’s CEO, Dr. Glynn Wilson, announced that through an exclusive agreement with the Mayo Clinic, TPIV has licensed a new antigen. According to Dr. Glynn this is expected to be a major game changer for the company! Read the full press release here http://finance.yahoo.com/news/chairman-ceo-tapimmune-says-licensed-131300784.html

We see a lot of potential here. The stock had a big move on April 05th and appears to be consolidating at this level before making the next leg.

As always read our disclaimer before investing in any stock.

ARNA‎ – Arena Pharmaceuticals, Inc. (NASDAQ) – is a clinical-stage biopharmaceutical company focused on discovering, developing and commercializing oral drugs that target G protein-coupled receptors, in four major therapeutic areas: cardiovascular, central nervous system, inflammatory and metabolic diseases. Arena’s advanced drug candidate is lorcaserin hydrochloride, for weight management, which has completed two pivotal Phase III clinical trials for lorcaserin. The Company’s wholly owned subsidiary, Arena Pharmaceuticals GmbH, has granted Eisai Inc., rights to commercialize lorcaserin in the United States and its territories and possessions subject to Food and Drug Administration approval of the lorcaserin new drug application. Its research and development programs also include APD597, APD916, APD791 and APD125, all of which are oral drug candidates

This video has a lot of good information on why this should be in your stock portfolio. http://www.youtube.com/watch?v=E4C8gV6gprU&feature=player_embedded

As always please read our disclaimer before investing in any stock.

It’s been a while since I have mentioned a stock, but with a huge amount of volume and interest this will be one to keep on your list of stocks to watch.

SunpeaksVentures, Inc (“Sunpeaks”), and wholly owned subsidiary Healthcare Distribution Specialists, LLC (“HDS”), is a nationally focused, value-added distributor of specialty drugs and over-the-counter (“OTC”) branded multivitamins to the healthcare provider market.  According to the Healthcare Distribution Management Association, about 85% of all prescription medications are sold through healthcare distributors in the United States, which amounts to $300 billion in revenue.  Currently, HDS serves the secondary segment of the specialty drug market, estimated by management to be a $45 billion market segment.  HDS currently functions as a just-in-time source of supply for hospitals for those products that are hard-to-find due to drug manufacturers’ production shortages. In 2011 alone, there were over 200 drug shortages and by FDA estimates, this problem is only expected to worsen as more pharmaceuticals go generic. In addition to pharmaceuticals, HDS also distributes over-the-counter (“OTC”) branded health supplements. Sunpeaks is currently analyzing several OTC products that would allow us to become a powerful Over-The-Counter player in the multi-billon dollar health supplement market.

As always be sure to read our disclaimer

BioSante Pharmaceuticals, inc. shares soared up 22% yesterday. We have had nothing but winners this month.

Congratulations are in order if you have been following my tweets. I am already up 20% this year in the first 4 days of the new year. NSRS made me a combined profit of 20%. I am now on to the next stock I think will help make me money. $BPAX. FDA decision on valentine’s day Feb 14th, 2012

BioSante Pharmaceuticals, Inc. (BioSante) is a specialty pharmaceutical company focused on developing products for female sexual health and oncology. BioSante products for female sexual health, menopause, contraception and male hypogonadism include its gel formulations of estradiol or testosterone and combinations of estrogen, progestogen and androgen. Its products in human clinical development, include LibiGel, Elestrin, Pill-Plus (triple component contraceptive), Bio-T-Gel and Cancer vaccines, a portfolio of cancer vaccines in Phase II clinical development for the treatment of various cancers. The Company is also developing its calcium phosphate technology (CaP) for aesthetic medicine (BioLook). Its portfolio of cancer vaccines is designed to stimulate the patient’s immune system to fight the patient’s own cancer. Multiple Phase II trials of these vaccines are ongoing in various cancer types, including pancreatic cancer, leukemia and breast cancer.

This past year was our first year really hitting the trading scene and all in all we have had a pretty decent year. Looking forward now to what 2012 brings and we are starting it off right with $NSRS

Are you looking to make quick gains? Well this site seems to exist for just that purpose. AwesomePennyStocks.com is a gateway to a  free subscription investment newsletter that focuses on buying penny stocks. Type in your email address and soon you will start receiving their newsletter with stock recommendations.

I have tried a couple of their recommendations over the past year and I have to admit I am pleasantly surprised with the results. I have managed to pull in a significant amount of money in a short period of time on their stock recommendations. It’s hard to believe some think their website is a Scam. The only thing I can figure is these people may have gotten in on the tail end of one of their recommendations and weren’t able to make money. Their last stock recommendation went from .13   to $1.33 in roughly a 3 week period.

Playing penny stocks definitely has its dangers.  They can move quick and can be a target for price manipulation so its important that you keep your wits about you while playing these stocks. You should never invest money you can’t afford to lose and while that goes for any stock, it’s especially true for penny stocks. There are plenty of other penny stock sites that provide recommendations, but in my experience this newsletter has provided me with the best results.

We made a nice call this morning on Evergreen Energy Inc. (Public, NYSEARCA:EEE) while it was still at .28 cents. Not long after our alert the stock hit .46 cents for a 60% increase. Not bad for a couple of hours work and the best part is it may not be over yet. This could end up going higher.

INGDirect has some great new account incentives. Check out their specials. On one of them you get $100 just for opening a new stock trade account and making 2 trades. Talk about rich in minutes!

http://www.ingdirect.com/blackfriday/

These are just a couple of things I think will help you when you are first starting out.

1. Create some rules. These are a couple of my rules:

• Down 9% in a stock, I cut my losses and move on.
• When I have made 100% of my investment on a stock I’ll sell 50%. This will give me my initial investment back and let the other half ride till I see that its lost momentum.

You’ll want to adjust these to your trading style and I am sure they should change as the amount of money your using changes.

2. Know your risk. Be Prepared.

Your not always going to be able to identify when a stock might go up or down, but if you watch how a stock trades before you get into it you will probably be in a better position. Review charts and history of the stock. Are you getting in at the bottom or at the 52 week high? Is there a Catalyst that will send the stock higher in the next month or months? When do earnings come out, if they are bad this could affect your position. You really have to think of all the things that may affect the price.

3. Relax. Take a breather.

If not about being in a stock everyday. Sometimes I will wait 2 weeks or more before buying another stock. While it does eat a me, I have to remind myself I waiting for the perfect opportunity to enter and leave a stock. These opportunities are not going to present themselves everyday and its better to wait for them to present themselves rather than me trying to create them.

4. Learn from your mistakes.

After doing this for over a year now I have learned a lot and I still learn everyday as I continue to build my wealth. I continue to modify my rules, Discuss different trading techniques with traders, and soak up as much as I can if it relates in any way to trading stocks.

5. Never invest what you can’t afford to lose

This one is extremely important. You will eventually lose money in the stock market and it could be on your first trade, so its important that you don’t use money you can’t afford to lose.